597 related articles for article (PubMed ID: 35196811)
1.
Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
[TBL] [Abstract][Full Text] [Related]
2.
Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
[TBL] [Abstract][Full Text] [Related]
3. Manogepix (APX001A)
Arendrup MC; Chowdhary A; Jørgensen KM; Meletiadis J
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32660998
[TBL] [Abstract][Full Text] [Related]
4.
Zhu Y; Kilburn S; Kapoor M; Chaturvedi S; Shaw KJ; Chaturvedi V
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839219
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6.
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
[TBL] [Abstract][Full Text] [Related]
7. Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020).
Pfaller MA; Huband MD; Rhomberg PR; Bien PA; Castanheira M
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0102822. PubMed ID: 36286491
[TBL] [Abstract][Full Text] [Related]
8. Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris
John LLH; Thomson DD; Bicanic T; Hoenigl M; Brown AJP; Harrison TS; Bignell EM
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0164522. PubMed ID: 37162367
[TBL] [Abstract][Full Text] [Related]
9.
O'Brien B; Chaturvedi S; Chaturvedi V
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019).
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
J Glob Antimicrob Resist; 2021 Sep; 26():117-127. PubMed ID: 34051400
[TBL] [Abstract][Full Text] [Related]
11. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
12. Manogepix (APX001A) Displays Potent
Arendrup MC; Jørgensen KM
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366708
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
[TBL] [Abstract][Full Text] [Related]
14. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.
Pfaller MA; Castanheira M; Lockhart SR; Ahlquist AM; Messer SA; Jones RN
J Clin Microbiol; 2012 Apr; 50(4):1199-203. PubMed ID: 22278842
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Vitek 2 system for antifungal susceptibility testing of
Siopi M; Pachoulis I; Leventaki S; Spruijtenburg B; Meis JF; Pournaras S; Vrioni G; Tsakris A; Meletiadis J
J Clin Microbiol; 2024 Apr; 62(4):e0152823. PubMed ID: 38501836
[TBL] [Abstract][Full Text] [Related]
16.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
17. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
18. Candida auris and multidrug resistance: Defining the new normal.
Lockhart SR
Fungal Genet Biol; 2019 Oct; 131():103243. PubMed ID: 31228646
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Six Antifungal Susceptibilities of 11
Lee H; Choi SH; Oh J; Koo J; Lee HJ; Cho SI; Shin JH; Lee HK; Kim SY; Lee CH; Kim YR; Sohn YH; Kim WJ; Ryu SW; Sung GH; Kim J
Microbiol Spectr; 2022 Apr; 10(2):e0125321. PubMed ID: 35384691
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
